Heparin Market Report

Europe Heparin Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 18, 2020
  • PAGES：145
  • REPORT CODE：GMM552615
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Heparin market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Heparin Market Segmentations:

    By Player:

    • Qianhong Bio-pharma

    • Bioibérica

    • Yino Pharma Limited

    • Jiulong Biochemicals

    • SPL(acquired by Hepalink in 2014)

    • Deebio

    • Pfizer

    • Changshan Pharm

    • Hepalink

    • Xinbai

    • King-friend Biochemical Pharmaceutical

    • Tiandong

    • Opocrin

    • SPL(acquired by Qianhong Bio-pharma in 2014)

    By Type:

    • Heparin Sodium

    • Heparin Calcium

    By End-User:

    • UFH

    • LMWH

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Heparin Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Heparin Market Size and Growth Rate of Heparin Sodium from 2014 to 2026

    • 1.3.2 Europe Heparin Market Size and Growth Rate of Heparin Calcium from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Heparin Market Size and Growth Rate of UFH from 2014 to 2026

    • 1.4.2 Europe Heparin Market Size and Growth Rate of LMWH from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Heparin Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Heparin Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Heparin Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Heparin by Major Types

      • 3.4.1 Market Size and Growth Rate of Heparin Sodium

      • 3.4.2 Market Size and Growth Rate of Heparin Calcium

    4 Segmentation of Heparin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Heparin by Major End-Users

      • 4.4.1 Market Size and Growth Rate of UFH for Construction

      • 4.4.2 Market Size and Growth Rate of LMWH for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Heparin Production Analysis by Top Regions

    • 5.2 Europe Heparin Consumption Analysis by Top Regions

    • 5.3 Europe Heparin Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Heparin Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Heparin Production, Import, Consumption and Export Analysis

      • 5.3.3 France Heparin Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Heparin Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Heparin Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Heparin Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Heparin Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Heparin Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Heparin Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Heparin Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Heparin Production, Import, Consumption and Export Analysis

    6 Product Circulation of Heparin Market among Top Countries

    • 6.1 Top 5 Export Countries in Heparin Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Heparin Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Heparin Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Heparin Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Heparin Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Heparin Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Heparin Landscape Analysis

    • 7.1 Germany Heparin Landscape Analysis by Major Types

    • 7.2 Germany Heparin Landscape Analysis by Major End-Users

    8. UK Heparin Landscape Analysis

    • 8.1 UK Heparin Landscape Analysis by Major Types

    • 8.2 UK Heparin Landscape Analysis by Major End-Users

    9. France Heparin Landscape Analysis

    • 9.1 France Heparin Landscape Analysis by Major Types

    • 9.2 France Heparin Landscape Analysis by Major End-Users

    10. Italy Heparin Landscape Analysis

    • 10.1 Italy Heparin Landscape Analysis by Major Types

    • 10.2 Italy Heparin Landscape Analysis by Major End-Users

    11. Spain Heparin Landscape Analysis

    • 11.1 Spain Heparin Landscape Analysis by Major Types

    • 11.2 Spain Heparin Landscape Analysis by Major End-Users

    12. Poland Heparin Landscape Analysis

    • 12.1 Poland Heparin Landscape Analysis by Major Types

    • 12.2 Poland Heparin Landscape Analysis by Major End-Users

    13. Russia Heparin Landscape Analysis

    • 13.1 Russia Heparin Landscape Analysis by Major Types

    • 13.2 Russia Heparin Landscape Analysis by Major End-Users

    14. Switzerland Heparin Landscape Analysis

    • 14.1 Switzerland Heparin Landscape Analysis by Major Types

    • 14.2 Switzerland Heparin Landscape Analysis by Major End-Users

    15. Turkey Heparin Landscape Analysis

    • 15.1 Turkey Heparin Landscape Analysis by Major Types

    • 15.2 Turkey Heparin Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Landscape Analysis by Top Countries

      • 16.3.1 Denmark Heparin Market Volume and Growth Rate

      • 16.3.2 Finland Heparin Market Volume and Growth Rate

      • 16.3.3 Norway Heparin Market Volume and Growth Rate

      • 16.3.4 Sweden Heparin Market Volume and Growth Rate

      • 16.3.6 Iceland Heparin Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Heparin Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Heparin Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Heparin Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Heparin Landscape Analysis by Top Countries

      • 17.3.1 Belgium Heparin Market Volume and Growth Rate

      • 17.3.2 Netherlands Heparin Market Volume and Growth Rate

      • 17.3.3 Luxembourg Heparin Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Heparin Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Heparin Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Heparin Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Heparin Landscape Analysis by Top Countries

      • 18.3.1 Estonia Heparin Market Volume and Growth Rate

      • 18.3.2 Latvia Heparin Market Volume and Growth Rate

      • 18.3.3 Lithuania Heparin Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Qianhong Bio-pharma

      • 19.1.1 Qianhong Bio-pharma Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Bioibérica

      • 19.2.1 Bioibérica Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Yino Pharma Limited

      • 19.3.1 Yino Pharma Limited Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Jiulong Biochemicals

      • 19.4.1 Jiulong Biochemicals Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 SPL(acquired by Hepalink in 2014)

      • 19.5.1 SPL(acquired by Hepalink in 2014) Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Deebio

      • 19.6.1 Deebio Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Pfizer

      • 19.7.1 Pfizer Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Changshan Pharm

      • 19.8.1 Changshan Pharm Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Hepalink

      • 19.9.1 Hepalink Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Xinbai

      • 19.10.1 Xinbai Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 King-friend Biochemical Pharmaceutical

      • 19.11.1 King-friend Biochemical Pharmaceutical Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Tiandong

      • 19.12.1 Tiandong Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Opocrin

      • 19.13.1 Opocrin Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 SPL(acquired by Qianhong Bio-pharma in 2014)

      • 19.14.1 SPL(acquired by Qianhong Bio-pharma in 2014) Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    The List of Tables and Figures (Totals 105 Figures and 153 Tables)

    • Figure Product Picture

    • Figure Heparin Market Size and Growth Rate of Heparin Sodium Market, 2015 - 2026 (USD Million)

    • Figure Heparin Market Size and Growth Rate of Heparin Calcium Market, 2015 - 2026 (USD Million)

    • Figure Heparin Market Size and Growth Rate of UFH from 2014 to 2026

    • Figure Heparin Market Size and Growth Rate of LMWH from 2014 to 2026

    • Figure Germany Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure UK Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure France Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Heparin Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Heparin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Heparin

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Heparin by Different Types from 2014 to 2026

    • Table Consumption Share of Heparin by Different Types from 2014 to 2026

    • Figure Heparin Market Size and Growth Rate of Heparin Sodium Market, 2015 - 2026 (USD Million)

    • Figure Heparin Market Size and Growth Rate of Heparin Calcium Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Heparin by Different End-Users from 2014 to 2026

    • Table Consumption Share of Heparin by Different End-Users from 2014 to 2026

    • Figure Heparin Market Size and Growth Rate of UFH from 2014 to 2026

    • Figure Heparin Market Size and Growth Rate of LMWH from 2014 to 2026

    • Table Europe Heparin Production by Major Regions

    • Table Europe Heparin Production Share by Major Regions

    • Figure Europe Heparin Production Share by Major Countries and Regions in 2014

    • Table Europe Heparin Consumption by Major Regions

    • Table Europe Heparin Consumption Share by Major Regions

    • Table Germany Heparin Production, Import, Consumption and Export Analysis

    • Table UK Heparin Production, Import, Consumption and Export Analysis

    • Table France Heparin Production, Import, Consumption and Export Analysis

    • Table Italy Heparin Production, Import, Consumption and Export Analysis

    • Table Spain Heparin Production, Import, Consumption and Export Analysis

    • Table Poland Heparin Production, Import, Consumption and Export Analysis

    • Table Russia Heparin Production, Import, Consumption and Export Analysis

    • Table Switzerland Heparin Production, Import, Consumption and Export Analysis

    • Table Turkey Heparin Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Heparin Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Heparin Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Heparin Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Heparin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Heparin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Heparin Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Heparin Consumption by Types from 2014 to 2026

    • Table Germany Heparin Consumption Share by Types from 2014 to 2026

    • Table Germany Heparin Consumption by End-Users from 2014 to 2026

    • Table Germany Heparin Consumption Share by End-Users from 2014 to 2026

    • Table UK Heparin Consumption by Types from 2014 to 2026

    • Table UK Heparin Consumption Share by Types from 2014 to 2026

    • Table UK Heparin Consumption by End-Users from 2014 to 2026

    • Table UK Heparin Consumption Share by End-Users from 2014 to 2026

    • Table France Heparin Consumption by Types from 2014 to 2026

    • Table France Heparin Consumption Share by Types from 2014 to 2026

    • Table France Heparin Consumption by End-Users from 2014 to 2026

    • Table France Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Italy Heparin Consumption by Types from 2014 to 2026

    • Table Italy Heparin Consumption Share by Types from 2014 to 2026

    • Table Italy Heparin Consumption by End-Users from 2014 to 2026

    • Table Italy Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Spain Heparin Consumption by Types from 2014 to 2026

    • Table Spain Heparin Consumption Share by Types from 2014 to 2026

    • Table Spain Heparin Consumption by End-Users from 2014 to 2026

    • Table Spain Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Poland Heparin Consumption by Types from 2014 to 2026

    • Table Poland Heparin Consumption Share by Types from 2014 to 2026

    • Table Poland Heparin Consumption by End-Users from 2014 to 2026

    • Table Poland Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Russia Heparin Consumption by Types from 2014 to 2026

    • Table Russia Heparin Consumption Share by Types from 2014 to 2026

    • Table Russia Heparin Consumption by End-Users from 2014 to 2026

    • Table Russia Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Heparin Consumption by Types from 2014 to 2026

    • Table Switzerland Heparin Consumption Share by Types from 2014 to 2026

    • Table Switzerland Heparin Consumption by End-Users from 2014 to 2026

    • Table Switzerland Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Heparin Consumption by Types from 2014 to 2026

    • Table Turkey Heparin Consumption Share by Types from 2014 to 2026

    • Table Turkey Heparin Consumption by End-Users from 2014 to 2026

    • Table Turkey Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Heparin Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Heparin Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Heparin Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Heparin Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Heparin Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Heparin Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Heparin Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Heparin Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Heparin Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Heparin Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Heparin Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Heparin Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Heparin Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Heparin Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Heparin Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Heparin Market Volume and Growth Rate from 2014 to 2026

    • Table Qianhong Bio-pharma Profiles

    • Table Qianhong Bio-pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Qianhong Bio-pharma Product benchmarking

    • Table Qianhong Bio-pharma Strategic initiatives

    • Table Qianhong Bio-pharma SWOT analysis

    • Table Bioibérica Profiles

    • Table Bioibérica Production, Value, Price, Gross Margin 2014-2019

    • Table Bioibérica Product benchmarking

    • Table Bioibérica Strategic initiatives

    • Table Bioibérica SWOT analysis

    • Table Yino Pharma Limited Profiles

    • Table Yino Pharma Limited Production, Value, Price, Gross Margin 2014-2019

    • Table Yino Pharma Limited Product benchmarking

    • Table Yino Pharma Limited Strategic initiatives

    • Table Yino Pharma Limited SWOT analysis

    • Table Jiulong Biochemicals Profiles

    • Table Jiulong Biochemicals Production, Value, Price, Gross Margin 2014-2019

    • Table Jiulong Biochemicals Product benchmarking

    • Table Jiulong Biochemicals Strategic initiatives

    • Table Jiulong Biochemicals SWOT analysis

    • Table SPL(acquired by Hepalink in 2014) Profiles

    • Table SPL(acquired by Hepalink in 2014) Production, Value, Price, Gross Margin 2014-2019

    • Table SPL(acquired by Hepalink in 2014) Product benchmarking

    • Table SPL(acquired by Hepalink in 2014) Strategic initiatives

    • Table SPL(acquired by Hepalink in 2014) SWOT analysis

    • Table Deebio Profiles

    • Table Deebio Production, Value, Price, Gross Margin 2014-2019

    • Table Deebio Product benchmarking

    • Table Deebio Strategic initiatives

    • Table Deebio SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Changshan Pharm Profiles

    • Table Changshan Pharm Production, Value, Price, Gross Margin 2014-2019

    • Table Changshan Pharm Product benchmarking

    • Table Changshan Pharm Strategic initiatives

    • Table Changshan Pharm SWOT analysis

    • Table Hepalink Profiles

    • Table Hepalink Production, Value, Price, Gross Margin 2014-2019

    • Table Hepalink Product benchmarking

    • Table Hepalink Strategic initiatives

    • Table Hepalink SWOT analysis

    • Table Xinbai Profiles

    • Table Xinbai Production, Value, Price, Gross Margin 2014-2019

    • Table Xinbai Product benchmarking

    • Table Xinbai Strategic initiatives

    • Table Xinbai SWOT analysis

    • Table King-friend Biochemical Pharmaceutical Profiles

    • Table King-friend Biochemical Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table King-friend Biochemical Pharmaceutical Product benchmarking

    • Table King-friend Biochemical Pharmaceutical Strategic initiatives

    • Table King-friend Biochemical Pharmaceutical SWOT analysis

    • Table Tiandong Profiles

    • Table Tiandong Production, Value, Price, Gross Margin 2014-2019

    • Table Tiandong Product benchmarking

    • Table Tiandong Strategic initiatives

    • Table Tiandong SWOT analysis

    • Table Opocrin Profiles

    • Table Opocrin Production, Value, Price, Gross Margin 2014-2019

    • Table Opocrin Product benchmarking

    • Table Opocrin Strategic initiatives

    • Table Opocrin SWOT analysis

    • Table SPL(acquired by Qianhong Bio-pharma in 2014) Profiles

    • Table SPL(acquired by Qianhong Bio-pharma in 2014) Production, Value, Price, Gross Margin 2014-2019

    • Table SPL(acquired by Qianhong Bio-pharma in 2014) Product benchmarking

    • Table SPL(acquired by Qianhong Bio-pharma in 2014) Strategic initiatives

    • Table SPL(acquired by Qianhong Bio-pharma in 2014) SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US